Literature DB >> 17767981

Seroprevalence of HBV in immigrant pregnant women and coverage of HBIG vaccine for neonates born to chronically infected immigrant mothers in Hsin-Chu County, Taiwan.

Ching-Yun Liu1, Nien-Tzu Chang, Pesus Chou.   

Abstract

This study was carried out to assess the prevalence of HBsAg positivity and coverage rate of antenatal HBV screening among immigrant women. In addition, the extent of administration of HBIG plus HB vaccine #1 to neonates born to chronically infected (HBeAg-positive/HBsAg-positive) mothers was assessed. All pregnant women residing in Hsin-Chu County, Taiwan and giving birth during 2004-2006 were recruited. Among all 16926 cases, the prevalence of HBsAg positivity according to their ethnicities was Mainland Chinese, 11.0% (68/616); Indonesian, 3.5% (15/426); Vietnamese, 7.4% (42/568); aboriginal Taiwanese, 20.6% (109/530); and non-aboriginal Taiwanese 11.5% (1536/13368). Among the HBsAg carriers, the prevalence of HBeAg positivity was Mainland Chinese, 52.9% (36/68); Indonesian, 53.3% (8/15); Vietnamese, 45.2% (19/42); aboriginal Taiwanese, 47.7% (52/109); and non-aboriginal Taiwanese, 26.8% (411/1534). With non-aboriginal Taiwanese as the reference category, results of multiple logistic regression revealed the healthy immigrant phenomenon in the HBsAg carriage state among pregnant women from Indonesia (OR 0.30; CI 95%: 0.18-0.50) and Vietnam (OR 0.68; CI 95%: 0.49-0.93). On the contrary, among chronically infected mothers, Mainland Chinese showed the highest risk for HBeAg positivity (OR 2.79; CI 95%: 1.7-4.58). More efforts should be made to improve HBV infection among aboriginal Taiwanese pregnant women who were more vulnerable to HBsAg positivity (OR 2.15; CI 95%: 1.72-2.68) and HBeAg positivity (OR 1.93; CI 95%: 1.28-2.90). Age was another independent predictor for HBsAg positivity (OR 1.02; CI 95%: 1.01-1.03) and for HBeAg positivity among chronically infected mothers (OR 0.93; CI 95%: 0.91-0.96). The coverage rates of antenatal HBV screening and HBIG plus HB vaccine #1 showed no difference among these multiple ethnic subgroups. In 2006, the overall coverage rate of antenatal HBV screening was 98.7% (5546/5639), with the individual rate being Mainland Chinese, 100% (267/267); Indonesian, 97.2% (106/109); Vietnamese, 99.5% (201/202); aboriginal Taiwanese, 97.0% (196/202); and non-aboriginal Taiwanese, 99.8% (4776/4785). The administration rate of HBIG plus HB vaccine #1 was 100% for all ethnic subgroups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17767981     DOI: 10.1016/j.vaccine.2007.07.056

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Breastfeeding and chronic HBV infection: clinical and social implications.

Authors:  Mihaela Petrova; Victor Kamburov
Journal:  World J Gastroenterol       Date:  2010-10-28       Impact factor: 5.742

2.  Tenofovir rescue therapy in pregnant females with chronic hepatitis B.

Authors:  Yu-Hong Hu; Min Liu; Wei Yi; Yan-Jun Cao; Hao-Dong Cai
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

3.  Safety of lamivudine treatment for chronic hepatitis B in early pregnancy.

Authors:  Wei Yi; Min Liu; Hao-Dong Cai
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

4.  Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment.

Authors:  Solomon Chih-Cheng Chen; Mehlika Toy; Jennifer M Yeh; Jung-Der Wang; Stephen Resch
Journal:  Pediatrics       Date:  2013-03-25       Impact factor: 7.124

5.  Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China.

Authors:  Yali Hu; Shu Zhang; Chao Luo; Qilan Liu; Yi-Hua Zhou
Journal:  BMC Infect Dis       Date:  2012-09-17       Impact factor: 3.090

6.  Epidemiology and aetiology of maternal bacterial and viral infections in low- and middle-income countries.

Authors:  Prasad Palani Velu; Courtney A Gravett; Tom K Roberts; Thor A Wagner; Jian Shayne F Zhang; Craig E Rubens; Michael G Gravett; Harry Campbell; Igor Rudan
Journal:  J Glob Health       Date:  2011-12       Impact factor: 4.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.